Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. [electronic resource]
Producer: 20201009Description: 1235-1242 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bendamustine Hydrochloride -- administration & dosage
- Bleomycin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Middle Aged
- Progression-Free Survival
- Recurrence
- Salvage Therapy -- methods
- Young Adult
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.